Endocrinology Activities
Advances in the Treatment of Schizophrenia: Integrating New and Emerging Options into Therapy to Meet Unmet Needs
0290-0000-20-123-H01-P
This activity will review the current treatment landscape of schizophrenia as well as evidence for novel therapies that have the potential to improve symptom management, optimize adherence, and reduce adverse effects.
1.50
Continuous Glucose Monitoring: Data Interpretation and the Role of the Pharmacist
0290-0000-20-101-H01-P
This activity will show pharmacists how to help patients understand what steps to take in their diabetes care, and will also motivate patients to adhere to CGM.
1.00
A Managed Care Review of Schizophrenia: Evaluating Unmet Medical Needs, New Treatments, and Health Economics
0290-0000-20-066-H01-P
This supplement will characterize common comorbidities, adherence challenges, and areas of unmet need within schizophrenia treatment.
3.50
Overview of CGM Technology and Available Devices
0290-0000-20-089-H01-P
This activity will enable pharmacists to become more comfortable counseling patients on how to use CGM devices and to better address questions and concerns that patients with diabetes may have.
1.00